Sağlıklı Çocuklarla, Dil ve Konuşma Bozukluğu Olan Çocuklar Arasında Vitamin D Düzeyinin Karşılaştırılması

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 11.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 9.0px Helvetica} ÖZAmaç: Bu çalışmada, dil ve konuşma bozukluğu olan çocuklar ile vitamin D (25(OH)D3) düzeyi arasındaki ilişki araştırıldı.Gereç ve Yöntemler: Toplam 200 çocuk çalışmaya alındı. Hasta olarak alınan 124 çocukta; kekemelik (n=62), fonksiyoneldil gelişim bozukluğu (n=40) ve artikülasyon bozukluğu (n=22) vardı. Kontrol grubuna 76 sağlıklı çocuk alındı.Hastalarda ve sağlıklı çocuklarda plazmada vitamin D seviyesine bakıldı.Bulgular: Vitamin D seviyesi; kekemeliği olanlarda 23.36±10.01, fonksiyonel dil gelişim bozukluğu olanlarda 17.82±8.28,artikülasyon bozukluğu olanlarda 23.68±10.95, kontrol grubunda 26.01±7.4 olarak saptandı. Artikülasyon ve kekemelikile kontrol grubu arasında vitamin D açısından anlamlı fark bulunmadı. Fonksiyonel dil gelişim bozukluğu olan çocuklarda,sağlıklı gruba göre vitamin D değeri daha düşüktü ve istatistiksel olarak anlamlı bir fark saptandı (p<0.001). Ayrıca,kekemelik şiddeti artıkça vitamin D seviyesinin düşük olduğu saptandı.Sonuç: Bu çalışmanın sonuçlarına göre, vitamin D düzeyi ile fonksiyonel dil gelişim bozukluğu arasında önemli bir bağlantıolduğu düşünülebilir. Ancak, yine de, dil ve konuşma bozukluğu olan çocuklarda bu bulguları doğrulamak için daha p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 11.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 9.0px Helvetica} fazla çalışmaya ihtiyaç olduğu kanaatindeyiz.

Anahtar Kelimeler:

Artikülasyon bozukluğu, Fonksiyonel dil bozukluğu, Kekemelik

A Comparison of Vitamin D Levels in Chidren with Language and Speech Disorders and Healthy Children in the Turkish Population

ABSTRACTObjective: This study aimed to investigate the relationship between vitamin D [25(OH)] values with the language andspeech disorders in children.Material and Methods: A total of 200 children were included in the study, comprising 124 children, with stuttering(n=62), functional language disorder (n=40) and articulation disorder (n=22) as the patient group and a control groupof 76 healthy children. Vitamin D levels were examined in blood samples taken from both the patient group and thecontrol group.Results: Serum vitamin D levels were determined as 23.68 ± 10.95 in patients with articulation disorder, 17.82 ± 8.28in patients with functional language disorder, 23.36 ± 10.01 in patients with stuttering, and 26.01 ± 7.4 in the controlgroup. Serum vitamin D values were found to be statistically significantly (p<0.001) lower in children with functionallanguage disorder than in the healthy control group. It was observed that vitamin D decreased as the severity of thestutter increased.Conclusion: According to the results of this study, there can be considered to be an important connection betweenvitamin D level and functional language disorder. Nevertheless, further studies are needed to confirm these findings in p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 11.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; font: 9.0px Helvetica} children with language and speech disorders.

Keywords:

Articulation disorder, Functional language disorder, Stuttering,

PDF

___

1. Silverman FH.Stuttering and Other Fluency Disorders. Illinois: Waveland Press. 2004
2. Maria-Mengel MR, Martins Linhares MB. Risk factors for infant developmental problems. Rev Lat Am Enfermagem 2007;15:837– 42.
3. Samra HA, Mcgrath JM, Wehbe M. An integrated review of developmental outcomes and late-preterm birth. J Obstet Gynecol Neonatal Nurs 2011;40:399–411.
4. Hall NE. Developmental Language Disorder. Semin Pediatr Neurol 1997;4:77-85.
5. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080-6.
6. Holick MF. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004;79:362-71.
7. Lemire JM, Archer DC. 1.25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 1991;87:1103-7.
8. Hanley DA, Cranney A, Jones G, Whiting SJ, Leslie WD, Cole DE, Atkinson SA, Josse RG, Feldman S, Kline GA, Rosen C. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:610-8.
9. Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a Neuroactive Substance:Review. Scientific World Journal 2006;26;125-139.
10. Sutherland MK, Wong L, Somerville MJ, Yoong LK, Bergeron C, Parmentier M, et al. Reduction of calbindin-24k mRNA levels in Alzheimer as compared to Huntington hippocampus. Brain Res Mol Brain Res 1993;18:32-42.
11. Schoenrock SA, Tarantino LM. Developmental vitamin D deficiency and schizophrenia: the role of animal models. Genes Brain Behav 2016;15:45-61.
12. McGrath J, Eyles D, Mowry B, Yolken R, Buka S. Low maternal vitamin D as a risk factor for schizophrenia:a pilot study using banked sera. Schizophr Res 2003;63:73-8.
13. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007;460:202-5.
14. American Psychiatric Association. Diagnostic criteria from DSM-IVTR. Washington DC: American Psychiatric Association 2000;370- 381.
15. Luu TM, Vohr BR, Schneider KC, Katz KH, Tucker R, Allan WC, et al. Trajectories of receptive language development from 3 to 12 years pf age for very preterm children. Pediatrics 2009;124;333- 41.
16. Martson L, Peacock JL, Calvert SA, Greenough A, Marlow N. Factors affecting vocabulary acquisition at age 2 in children born between 23 and 28 weeks’ gestation. Dev Med Child Neurol 2007;49:591–6.
17. Mossabeb R, Wake KC, Finnegan K, Sivieri E, Abbasi S. Language development survey provides a useful screening tool for language delay in preterm infants. Clin Pediatr (Phila) 2012;51:638-44.
18. Ouma S, Suenaga M, Bölükbaşı Hatip FF, Hatip-Al-Khatib I, Tsuboi Y, Matsunaga Y. Serum vitamin D in patients with mild cognitive impairment and Alzheimer’s disease. Brain Behav 2018;8:e00936.
19. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100-5.
20. Brown J, Bianco JI, McGrath JJ, Eyles DW. 1.25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003;343:139-43.
21. Munger KL, Zhang SM, O’Reilly E, Hernan MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62;60-5.
22. Mackay-Sim A, Feron F, Eyles D, Burne T, McGrath J. 2004. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol 59:351-80.
23. Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry 2016;25:453-4.
24. Brookes GB. Vitamin D deficiency and deafness: 1984 update. Am J Otology 1985;6:102–7.
25. Lemire J. 1,25-Dihydroxyvitamin D3-a hormone with immunomodulatory properties. Z Rheumatol 2000;59:24-7.
26. Garcion E, Thanh XD, Bled F, Teissier E, Dehouck MP, Rigault F, Bet al. 1.25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neurosci Lett 1996;216;183-6.
27. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002;13:100-5.
28. Ludlow CL, Loucks T. Stuttering: a dynamic motor control disorder. J Fluen Disord 2003;28:273-95.
29. Pool KD, Devous MD, Freeman FJ, Watson BC, Finitzo T. Regional cerebral blood flow in developmental stutterers. Arch Neurol 1991;48:509-12.
30. Yairi E, Ambrose N. Epidemiology of stuttering: 21st century advances. J Fluency Disord 2013;38:66-87.
31. Lawrence M, Barclay DM. Stuttering: A brief review. Am Fam Physician 1998;57:2175-8.
32. Wu JC, Maguire G, Riley G, Lee A, Keator D, Tang C, Fallon J, Najafi A. Increased dopamine activity associated with stuttering, Neuroreport 1997;8:767-70.
33. Steidl L, Pesak J, Chytilova H. Stuttering and tetanic syndrome. Folia Phoniatr (Basel) 1991;43:7-12.
34. Alm PA. Copper in developmental stuttering. Folia Phoniatr Logop 2005;57:216-22.
35. Rutter MJ, Bishop D, Pine D, Scott S, Stevenson JS, Taylor EA, Thapar A. Rutter’s child and adolescent psychiatry. 5th. Hoboken (NJ): Wiley-Blackwell 2010
36. Harrison LJ, McLeod S. Risk and protective factors associated with speech and language impairment in a nationally representative sample of 4- to 5-year-old children. J Speech Lang Hear Res 2010;53:508-29.
37. Yasin A, Aksu H, Ozgür E, Ozgür BG. Speech and language delay in childhood: a retrospective chart review. ENT Updates 2017;7;22-7.

Türkiye Çocuk Hastalıkları Dergisi-Cover

ISSN: 1307-4490
Başlangıç: 2007
Yayıncı: -

Arşiv

Sayıdaki Diğer Makaleler

AKRAN ZORBALIĞI

Tuna ÇAK ESEN

Sağlıklı Çocuklarla, Dil ve Konuşma Bozukluğu Olan Çocuklar Arasında Vitamin D Düzeyinin Karşılaştırılması

Saime SAĞIROĞLU